Racing Evolution: A new strategy for antibiotic synthesis By Alan Yang When it comes to antibiotics, the pace of our discoveries …
“Increasing the minimum number of required studies may be the shift we need to make antidepressants on the market safe and effective. If a drug is rushed to become profitable at the cost of reduced efficacy, the medicine’s true purpose is lost along the fast track to approval.”
By Osaremen Okolo
The loss of a friend highlights why organ donation is such a difficult issue for Americans.
By Charissa Iluore
Cancer and Von Hippel-Lindau disease are both tumour illnesses. Why has only one of them captured the public imagination?
By Layla Stahr
Where public access to research can go wrong
Human evolutionary biology junior Khin-Kyemon Aung explains how working at a mobile clinic has shaped her assistant editorship at Health Care.